175 related articles for article (PubMed ID: 9021806)
1. Colony-stimulating factors after the treatment of pediatric malignant diseases.
Schuler D
Pediatr Hematol Oncol; 1997; 14(1):iii-v. PubMed ID: 9021806
[No Abstract] [Full Text] [Related]
2. Clinical use of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in neutropenia associated with malignancy.
Lifton R; Bennett JM
Hematol Oncol Clin North Am; 1996 Aug; 10(4):825-39. PubMed ID: 8811304
[TBL] [Abstract][Full Text] [Related]
3. Colony-stimulating factors for adjunctive therapy of infections in neutropenic cancer patients.
Mayordomo JI; Rivera F; Cortes-Funes H
Support Care Cancer; 1995 Jan; 3(1):84-5. PubMed ID: 7535169
[No Abstract] [Full Text] [Related]
4. Clinical applications of hematopoietic growth factors in pediatric oncology.
Levine JE; Boxer LA
Curr Opin Hematol; 2002 May; 9(3):222-7. PubMed ID: 11953668
[TBL] [Abstract][Full Text] [Related]
5. Colony-stimulating factors stimulate some treatments, continue to evolve.
Volkers N
J Natl Cancer Inst; 1999 Feb; 91(3):210-2. PubMed ID: 10037097
[No Abstract] [Full Text] [Related]
6. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and rhG-CSF in the treatment of a child with severe chronic neutropenia.
Mori PG; Pasino M; Dufour C; Boeri E; Molinari AC
Blood; 1994 Nov; 84(9):3244-5. PubMed ID: 7524771
[No Abstract] [Full Text] [Related]
7. Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
Morstyn G; Sheridan W; Lieschke G; Cebon J; Layton J; Fox R
Prog Clin Biol Res; 1990; 354B():29-36. PubMed ID: 1700441
[No Abstract] [Full Text] [Related]
8. Clinical use of subcutaneous G-CSF or GM-CSF in malignancy.
Disis ML
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 2):5-9. PubMed ID: 15934493
[No Abstract] [Full Text] [Related]
9. [Place of CSF in pediatric oncology].
Hartmann O; Valteau-Couanet D
Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
[No Abstract] [Full Text] [Related]
10. Colony-stimulating factors.
Gordon MS; Gabrilove JL
Curr Opin Oncol; 1990 Dec; 2(6):1152-8. PubMed ID: 1712236
[No Abstract] [Full Text] [Related]
11. Interactive discussion on chemotherapy-related adverse events.
Adams VR; Lyman GH
Pharmacotherapy; 2000 Jul; 20(7 Pt 2):121S-125S. PubMed ID: 10905688
[No Abstract] [Full Text] [Related]
12. Anesthetic considerations in patients receiving colony-stimulating factors (G-CSF and GM-CSF).
Tobias JD; Furman WL
Anesthesiology; 1991 Sep; 75(3):536-8. PubMed ID: 1716081
[No Abstract] [Full Text] [Related]
13. [Autologous transplantation of hematopoietic stem cells and growth factors].
Harousseau JL
Pathol Biol (Paris); 1993 Jan; 41(1):50. PubMed ID: 7686287
[No Abstract] [Full Text] [Related]
14. [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
Balwierz W; Moryl-Bujakowska A; Balwierz A; Pawińska K
Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890
[TBL] [Abstract][Full Text] [Related]
15. The role of colony stimulating factors in cancer therapy.
Morstyn G; Sheridan WP
Cancer Chemother Biol Response Modif; 1991; 12():307-26. PubMed ID: 1718376
[No Abstract] [Full Text] [Related]
16. Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.
Lehrnbecher T; Creutzig U
Expert Rev Hematol; 2009 Apr; 2(2):159-72. PubMed ID: 21083449
[TBL] [Abstract][Full Text] [Related]
17. Colony-stimulating factors in the prevention and management of infectious diseases.
Page AV; Liles WC
Infect Dis Clin North Am; 2011 Dec; 25(4):803-17. PubMed ID: 22054757
[TBL] [Abstract][Full Text] [Related]
18. A tale of two growth factors.
Fruehauf JP; Kong KM; Wong SF; Chan HO
Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
[No Abstract] [Full Text] [Related]
19. Colony-stimulating factors for neutropenia in glycogen storage disease Ib.
Schroten H; Wendel U; Burdach S; Roesler J; Breidenbach T; Schweitzer S; Zeidler C; Welte K
Lancet; 1991 Mar; 337(8743):736-7. PubMed ID: 1706047
[No Abstract] [Full Text] [Related]
20. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
